8 Coupons
-
Special Offer
-
30% off
the house has passed an order extending the public health committee's reporting deadline for cusack's bill. .
all programs
-
.
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
advertisement
.